Cell Cycle Deregulation and<i>TP53</i>and<i>RAS</i>Mutations Are Major Events in Poorly Differentiated and Undifferentiated Thyroid Carcinomas

Abstract

Overall, this study identified crucial roles for TP53, RAS, CDKI, and TGF-β pathway, which may represent feasible therapeutic targets for ATC and PDTC treatment.